Forte Biosciences (FBRX) Other Working Capital Changes (2016 - 2026)

Forte Biosciences (FBRX) has 11 years of Other Working Capital Changes data on file, last reported at $3.2 million in Q1 2026.

• Other Working Capital Changes for Q1 2026 came in at $3.2 million, up 294.82% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.4 million (up 67281.82% YoY), and the FY2025 annual result was $2.6 million, up 87.47% from the prior year.
• Other Working Capital Changes grew to $3.2 million in Q1 2026 per FBRX's latest filing, from $2.2 million in the prior quarter.
• Over five years, Other Working Capital Changes peaked at $3.2 million in Q1 2026 and troughed at -$1.6 million in Q1 2025.
• A 5-year average of $455000.0 and a median of $17000.0 in 2024 frame the typical range for Other Working Capital Changes.
• On a YoY basis, Other Working Capital Changes climbed as much as 15269.23% in 2025 and fell as far as 488.17% in 2025.
• A 5-year view of Other Working Capital Changes shows it stood at -$182000.0 in 2022, then soared by 182.42% to $150000.0 in 2023, then surged by 981.33% to $1.6 million in 2024, then soared by 33.54% to $2.2 million in 2025, then jumped by 47.6% to $3.2 million in 2026.
• Business Quant data shows FBRX's Other Working Capital Changes at $3.2 million in Q1 2026, $2.2 million in Q4 2025, and $2.0 million in Q3 2025.